HSE approves use of Spinraza drug

The medication is used mostly by children with Spinal Muscular Atrophy (SMA).

HSE approves use of Spinraza drug
Tue, 11 Jun, 2019 - 15:16
Digital Desk staff

The HSE has today approved the use of the new drug Spinraza.

The medication is used mostly by children with Spinal Muscular Atrophy (SMA).

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €12/month. Ts&Cs apply.

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

School stock Sustainability of special class growth questioned with amount almost doubling in four years
AI prompt chat bot. Search website to generate data, text or image. Man using computer with artificial intelligence app. Virtual Climate change a bigger threat to humanity than 'science fiction' predictions on AI, UCC scientist says
Female employee having health problems at workplace Female whistleblowers more likely to suffer negative consequences, report finds
CourtsHealthSpinrazaPlace: IrelandPerson: Minister for HealthPerson: Simon HarrisOrganisation: HSEOrganisation: Biogen
<p>The incident happened at around 6.30am on Mellowes Road in Finglas. Picture Denis Minihane.</p>

Cyclist, 20s, hospitalised after two-car crash in Dublin

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited